Alcon Inc.
HealthcareNYSE:ALC · New York Stock Exchange
+$0.18 today
Vol 0.76M · Avg 1.93M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $1.6B |
| Short-term Investments | $81.4M |
| Receivables | $2.0B |
| Inventory | $2.5B |
| Other Current | $515.8M |
| Total Current Assets | $6.7B |
| PP&E (Net) | $5.3B |
| Goodwill | $9.3B |
| Intangible Assets | $8.9B |
| Long-term Investments | $804.4M |
| Tax Assets | $466.5M |
| Other Non-current | $378.0M |
| Total Non-current Assets | $25.1B |
| Total Assets | $31.8B |
Analysis
Selected assets total $31.8B for Latest. The largest visible component is Goodwill at $9.3B, about 29.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.5B -8.9% | $1.7B +53.2% | $1.1B +11.6% | $980.0M -37.8% | $1.6B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $80.0M -48.1% | $154.0M +2100.0% | $7.0M | $0 -100.0% | $3.0M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $1.9B -6.7% | $2.1B +10.4% | $1.9B -5.2% | $2.0B +24.9% | $1.6B | $533.8M | $399.4M | -$1.7B |
| Inventory | $2.4B +5.4% | $2.3B -2.3% | $2.3B +10.1% | $2.1B +11.1% | $1.9B | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $509.0M +4141.7% | $12.0M -94.7% | $226.0M +2725.0% | $8.0M -96.4% | $224.0M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $6.4B +2.2% | $6.3B +11.7% | $5.6B +8.7% | $5.2B -3.6% | $5.4B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $5.2B +7.9% | $4.8B +2.4% | $4.7B +7.0% | $4.4B +8.2% | $4.1B | $1.2B | $1.5B | $687.8M |
| Goodwill | $9.3B +3.5% | $8.9B +0.2% | $8.9B -0.5% | $9.0B +0.7% | $8.9B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $9.0B +4.9% | $8.6B -5.2% | $9.1B -6.5% | $9.7B +10.5% | $8.8B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $768.0M +2.3% | $751.0M +135.4% | $319.0M +195.4% | $108.0M +107.7% | $52.0M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 -100.0% | $421.0M -5.0% | $443.0M +7.8% | $411.0M +0.5% | $409.0M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $855.0M +72.7% | $495.0M -0.2% | $496.0M +17.5% | $422.0M +5.8% | $399.0M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $25.1B +4.4% | $24.0B +0.3% | $24.0B -0.2% | $24.0B +6.2% | $22.6B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $31.6B +4.0% | $30.3B +2.5% | $29.6B +1.4% | $29.2B +4.3% | $28.0B | $13.3B | $11.9B | $10.6B |
| Account Payables | $926.0M +19.8% | $773.0M -4.7% | $811.0M -5.8% | $861.0M -4.7% | $903.0M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $575.0M +469.3% | $101.0M +110.4% | $48.0M -50.5% | $97.0M -9.3% | $107.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $163.0M -11.9% | $185.0M -41.6% | $317.0M +13.2% | $280.0M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 -100.0% | $72.8M -6.6% | $78.0M -12.4% | $89.0M -17.6% | $108.0M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $1.5B +172.3% | $539.2M -14.0% | $627.0M -30.9% | $907.0M +54.8% | $586.0M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $3.0B +33.8% | $2.3B -5.0% | $2.4B -12.4% | $2.7B +10.8% | $2.5B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $4.2B -8.3% | $4.5B -3.0% | $4.7B +3.0% | $4.5B +14.5% | $4.0B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 -100.0% | $724.0M -9.2% | $797.0M -25.1% | $1.1B +3.7% | $1.0B | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 -100.0% | $86.0M +168.8% | $32.0M | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $1.9B +154.4% | $739.0M -1.7% | $752.0M -4.3% | $786.0M -16.4% | $940.0M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $6.5B -0.7% | $6.5B -1.2% | $6.6B -2.3% | $6.8B +7.6% | $6.3B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $9.5B +8.3% | $8.8B -2.2% | $9.0B -5.7% | $9.5B +9.0% | $8.7B | $14.7B | $3.7B | $9.6B |
| Common Stock | $20.0M +0.0% | $20.0M +0.0% | $20.0M +0.0% | $20.0M +0.0% | $20.0M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $0 | $0 | $0 | $0 | $0 | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $22.0B +2.2% | $21.5B +4.5% | $20.6B +4.8% | $19.7B +2.2% | $19.2B | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $1.0M | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $22.0B +2.2% | $21.6B +4.5% | $20.6B +4.8% | $19.7B +2.2% | $19.3B | $9.1B | $7.7B | $3.3B |
| Total Debt | $5.2B +2.1% | $5.1B +0.0% | $5.1B +1.3% | $5.1B +13.2% | $4.5B | $724.2M | $410.6M | $399.4M |
| Net Debt | $3.7B +7.7% | $3.5B -14.6% | $4.0B -1.1% | $4.1B +40.8% | $2.9B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Becton, Dickinson and Company
NYSE:BDX
$52.84B
Cardinal Health, Inc.
NYSE:CAH
$52.46B
Humana Inc.
NYSE:HUM
$45.39B
Agilent Technologies, Inc.
NYSE:A
$36.57B
IQVIA Holdings Inc.
NYSE:IQV
$29.88B
GE HealthCare Technologies Inc.
NASDAQ:GEHC
$29.52B
ResMed Inc.
NYSE:RMD
$28.07B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.26B
Mettler-Toledo International Inc.
NYSE:MTD
$22.83B
Insmed Incorporated
NASDAQ:INSM
$21.22B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does ALC have?
Alcon Inc. (ALC) reported $1.53B in cash and equivalents in fiscal 2025.
How much debt does ALC carry?
Alcon Inc. (ALC) reported $5.25B of total debt, with net debt of $3.72B.
Explore More
Continue the stock analysis
Jump to another research area for this company.